An Injectable Thermosensitive Hydrogel Codelivering Permeability-Promoting Nintedanib-loaded Phase-transition Nanoparticles and Doxorubicin to Potentiate Immunogenic Cell Death in Triple-Negative Breast Cancer for Chemoimmunotherapy